Physician
Edinburg Pediatric Network LLC
Edinburg Pediatric Network LLC was paid $37.30M by Medicaid between Jan 2018 and Dec 2024, across 108 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoEDINBURG PEDIATRIC NETWORK LLC
PHARR, TX 78577
PHARR, TX 78577
33aNPI1669708780assigned 10/23/2009
33bProvider typeGeneral Practice Physician
28Total paid$37.30M
24GClaims1,698,831
24DCodes billed108
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Texas
Rank by total paid#2 of 113
Median peer was paid$22K
This provider vs. median1,692×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,405 | $166K | |
| 2019 | 6,149 | $179K | |
| 2020 | 85,653 | $1.99M | |
| 2021 | 387,271 | $8.65M | |
| 2022 | 532,192 | $11.45M | |
| 2023 | 429,561 | $9.47M | |
| 2024incomplete | 252,600 | $5.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 323,421 | 277,242 | $9.26M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 17% | 156,497 | 144,812 | $6.27M |
| S8301 | Infection control supplies, not otherwise specified | 14% | 178,055 | 156,623 | $5.18M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.1% | 246,491 | 115,806 | $2.26M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.4% | 25,782 | 25,325 | $2.02M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.7% | 21,801 | 21,238 | $1.76M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.5% | 22,583 | 22,002 | $1.68M |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.4% | 137,036 | 128,567 | $1.27M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.9% | 105,369 | 51,442 | $1.10M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.4% | 12,405 | 12,090 | $902K |
| 99050 | 2.2% | 13,550 | 13,215 | $823K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.2% | 24,460 | 22,721 | $814K |
96 more codes
| 99429 | 1.4% | 16,474 | $533K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 74,378 | $326K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,193 | $247K |
| 87807 | <1% | 30,909 | $226K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,911 | $221K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 27,189 | $216K |
| 99381 | <1% | 2,552 | $196K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 4,189 | $181K |
| 87428 | <1% | 3,981 | $154K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,612 | $142K |
| 97803 | <1% | 6,018 | $117K | |
| 99000 | <1% | 15,639 | $114K | |
| 90461 | <1% | 15,506 | $109K | |
| 97802 | <1% | 2,797 | $99K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,396 | $90K |
| 87301 | <1% | 10,710 | $69K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,949 | $69K |
| 0001A | <1% | 1,752 | $68K | |
| 0002A | <1% | 1,645 | $64K | |
| 84481 | <1% | 6,097 | $58K | |
| 83525 | <1% | 8,136 | $55K | |
| 0071A | <1% | 1,548 | $51K | |
| 80061 | Lipid panel | <1% | 6,245 | $47K |
| 96161 | <1% | 21,985 | $44K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,899 | $41K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 3,601 | $37K |
| 0072A | <1% | 870 | $34K | |
| 99051 | <1% | 8,036 | $34K | |
| 84439 | <1% | 6,186 | $32K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,224 | $31K |
| 87631 | <1% | 397 | $28K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,264 | $24K |
| 81003 | <1% | 13,926 | $18K | |
| 80050 | General health panel | <1% | 674 | $17K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 188 | $15K |
| S9470 | Nutritional counseling, dietitian visit | <1% | 359 | $14K |
| 86328 | <1% | 570 | $13K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 35 | $13K |
| 86318 | <1% | 1,072 | $13K | |
| 86580 | <1% | 1,684 | $12K | |
| 84436 | <1% | 1,954 | $9K | |
| 99383 | <1% | 101 | $9K | |
| 87581 | <1% | 420 | $8K | |
| 84479 | <1% | 1,856 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 854 | $8K |
| 97170 | <1% | 120 | $6K | |
| 0004A | <1% | 174 | $6K | |
| 78268 | <1% | 103 | $5K | |
| 81025 | <1% | 664 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 147 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 164 | $2K |
| 0012A | <1% | 75 | $2K | |
| CP002 | <1% | 202 | $2K | |
| 90651 | <1% | 4,335 | $2K | |
| 90686 | <1% | 19,402 | $2K | |
| 82948 | <1% | 395 | $1K | |
| 87486 | <1% | 35 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 96 | $903.68 |
| 87425 | <1% | 118 | $764.56 | |
| 0073A | <1% | 18 | $720.00 | |
| 0011A | <1% | 66 | $691.30 | |
| 0003A | <1% | 16 | $640.00 | |
| 78267 | <1% | 103 | $575.98 | |
| 87634 | <1% | 18 | $524.08 | |
| 90734 | <1% | 4,658 | $450.71 | |
| 97169 | <1% | 17 | $387.60 | |
| 90656 | <1% | 1,773 | $244.65 | |
| 90670 | <1% | 7,470 | $216.82 | |
| 86308 | <1% | 38 | $108.75 | |
| 93000 | <1% | 12 | $104.58 | |
| 90715 | <1% | 1,744 | $93.08 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $85.73 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 861 | $78.05 |
| 94760 | <1% | 740 | $50.16 | |
| 96160 | <1% | 9,157 | $20.48 | |
| 90620 | <1% | 2,556 | $1.59 | |
| 90677 | <1% | 892 | $1.48 | |
| 90671 | <1% | 927 | $0.98 | |
| 91301 | <1% | 191 | $0.06 | |
| 91300 | <1% | 3,938 | $0.04 | |
| 90723 | 0% | 2,597 | $0.00 | |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 2,901 | $0.00 |
| 91307 | 0% | 2,619 | $0.00 | |
| 90680 | 0% | 5,006 | $0.00 | |
| 90698 | 0% | 576 | $0.00 | |
| 90697 | 0% | 864 | $0.00 | |
| 90696 | 0% | 1,299 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 173 | $0.00 |
| 90657 | 0% | 42 | $0.00 | |
| 90688 | 0% | 26 | $0.00 | |
| 90619 | 0% | 13 | $0.00 | |
| 90648 | 0% | 5,291 | $0.00 | |
| 90633 | 0% | 4,503 | $0.00 | |
| 90710 | 0% | 4,085 | $0.00 | |
| 90700 | 0% | 1,133 | $0.00 | |
| 91308 | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARCIA, MILDRED (SUPERVISOR)